Pathstone Family Office’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
Other funds holding OMCL
CIP
CS
GCM
Pathstone Family Office's OMCL Position: Q3 2023 in Review
Pathstone Family Office reduced its Omnicell (OMCL) stake by 11% in Q3 2023, selling an estimated $57.3K and leaving 7,886 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #1210.
Pathstone Family Office first reported a position in OMCL in Q1 2019 and has held it in 12 quarters since. The position peaked at $2.25M in Q4 2021. 312 funds tracked by Wall St. Rank hold OMCL as of Q3 2023.
- Pathstone Family Office held 7,886 shares of Omnicell worth $355K as of Q3 2023.
- Pathstone Family Office sold 946 Omnicell shares in Q3 2023, an estimated $57.3K.
- Omnicell made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1210 holding.
- Pathstone Family Office first reported a position in Omnicell in Q1 2019 and has held it in 12 quarters since.
- Pathstone Family Office's Omnicell position peaked at $2.25M in Q4 2021.
- 312 funds tracked by Wall St. Rank held Omnicell as of Q3 2023.
Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.